glp-1 vs sglt2 diabetes Receptor Agonists and Inhibitors in Type 2 Diabetes: Pleiotropic Cardiometabolic Effects and Add-on Value of a Combined Therapy | Drugs Recommendations for SGLT2i versus GLP-1

Clinical studies over the past two decades have consistently shown reduced toxicity and improved outcomes with PK dose management

Best Sellers KLOW A quad-peptide combination of BPC-157, TB-500, GHK-Cu, and KPV targeting complementary angiogenic, cellular migration, extracellular matrix remodeling, and anti-inflammatory pathways in preclinical research

At TrimRx, our commitment to personalized care means we are here to support you every step of the way

Corbisier P

CV: cardiovascular, CVD: cardiovascular disease, MI: myocardial infarction, HF: heart failure, ACS: acute coronary syndrome, NT-proBNP: N terminal-prohormone of brain natriuretic peptide